Zhang YC - Search Results

1

PARP in colorectal cancer: Molecular mechanisms, immunity, clinical trials, and drug combinations.

Wu FH, Wei HZ, Deng HY, Xiao GH, Zhang YC. Wu FH, et al. Among authors: zhang yc. Neoplasma. 2023 Feb;70(1):1-14. doi: 10.4149/neo_2022_220724N745. Epub 2022 Aug 30. Neoplasma. 2023. PMID: 36129834 Review.

2

Novel Oxovanadium Complex VO(hntdtsc)(NPIP): Anticancer Activity and Mechanism of Action on HeLa Cells.

Bai Y, Zhang H, Wang Y, Zhu L, Shi T, Wei H, Xiao J, Zhang Y, Wang Z. Bai Y, et al. Front Pharmacol. 2021 Feb 8;11:608218. doi: 10.3389/fphar.2020.608218. eCollection 2020. Front Pharmacol. 2021. PMID: 33628179 Free PMC article.

3

Bioinformatics Profiling of Five Immune-Related lncRNAs for a Prognostic Model of Hepatocellular Carcinoma.

Wu F, Wei H, Liu G, Zhang Y. Wu F, et al. Front Oncol. 2021 May 28;11:667904. doi: 10.3389/fonc.2021.667904. eCollection 2021. Front Oncol. 2021. PMID: 34123835 Free PMC article.

4

Periostin: a predictable molecule to prognosis and chemotherapy responses of gastrointestinal and hepato-biliary-pancreatic malignant tumors?

Zhang W, Wu FH, Wang J, Wei HZ, Wang TW, Zhang YC. Zhang W, et al. Among authors: zhang yc. Neoplasma. 2022 May;69(3):491-503. doi: 10.4149/neo_2021_211025N1521. Epub 2022 Feb 2. Neoplasma. 2022. PMID: 35103480

5

Measurement of soluble PD-1 and soluble PD-L1 as well as PD-L1 and PD-1 from perioperative patients with gastric carcinoma.

Wei H, Wu F, Mao Y, Zhang Y, Leng G, Wang J, Zhang W, Wang T. Wei H, et al. Jpn J Clin Oncol. 2022 Apr 6;52(4):331-345. doi: 10.1093/jjco/hyab214. Jpn J Clin Oncol. 2022. PMID: 35106596

6

The histidine phosphatase LHPP: an emerging player in cancer.

Wu F, Ma H, Wang X, Wei H, Zhang W, Zhang Y. Wu F, et al. Cell Cycle. 2022 Jun;21(11):1140-1152. doi: 10.1080/15384101.2022.2044148. Epub 2022 Mar 3. Cell Cycle. 2022. PMID: 35239447 Free PMC article. Review.

7

CTPS1 inhibition suppresses proliferation and migration in colorectal cancer cells.

Wu F, Mao Y, Ma T, Wang X, Wei H, Wang T, Wang J, Zhang Y. Wu F, et al. Cell Cycle. 2022 Dec;21(24):2563-2574. doi: 10.1080/15384101.2022.2105084. Epub 2022 Aug 1. Cell Cycle. 2022. PMID: 35912542 Free PMC article.

8

Osteopontin and its downstream carcinogenic molecules: regulatory mechanisms and prognostic value in cancer progression.

Chen L, Huan X, Xiao GH, Yu WH, Li TF, Gao XD, Zhang YC. Chen L, et al. Among authors: zhang yc. Neoplasma. 2022 Dec;69(6):1253-1269. doi: 10.4149/neo_2022_220507N489. Epub 2022 Aug 11. Neoplasma. 2022. PMID: 35951454 Review.

9

CCDC25 may be a potential diagnostic and prognostic marker of hepatocellular carcinoma: Results from microarray analysis.

Deng H, Zhang J, Zheng Y, Li J, Xiao Q, Wei F, Han W, Xu X, Zhang Y. Deng H, et al. Front Surg. 2022 Sep 23;9:878648. doi: 10.3389/fsurg.2022.878648. eCollection 2022. Front Surg. 2022. PMID: 36211267 Free PMC article.

10

Licoricidin combats gastric cancer by targeting the ICMT/Ras pathway in vitro and in vivo.

Ma H, Wu F, Bai Y, Wang T, Ma S, Guo L, Liu G, Leng G, Kong Y, Zhang Y. Ma H, et al. Front Pharmacol. 2022 Oct 13;13:972825. doi: 10.3389/fphar.2022.972825. eCollection 2022. Front Pharmacol. 2022. PMID: 36339587 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,302 results

Search Page

Filters